[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Rethink Medical SL\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":75},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100505351","comparative-study-between-foley-and-t-control-catheter-in-patients-with-long-term-catheterization-100505351",false,"NCT05860231","Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization","Comparative Mixed Study of the Foley Catheter With the T-Control® Catheter in Patients With Long-term Catheterization","Inclusion Criteria:\n\n* Man or women equal or over 18 years old\n* Patients who require a change of bladder catheter.\n* Indication of bladder catheterization for 4 weeks.\n* Maintained cognitive and physical capacity for self-monitoring of the T-Control ® catheter valve.\n* Agree to participate in the study and sign the informed consent.\n\nExclusion Criteria:\n\n* Symptoms of infection at the time of inclusion in the study.\n* Use of current antibiotic treatment or in the 2 weeks prior to inclusion in the study.\n* Patients with malformations in the urinary tract\n* Immunocompromised patients, diagnosed with cancer or AIDS.\n* Urological cancer patients\n* Patients who require continuous urine drainage (in the case of patients in the study arm) or hourly urine output measurement.\n* Catheter insertion requiring more than one attempt.\n* Inability to read and understand Spanish","ALL","18 Years",{"count":19,"type":20},50,"ESTIMATED","INTERVENTIONAL",[23],"NA","This is a comparative, randomized, controlled pilot study. The main objective of this study is to evaluate the efficacy, comfort, and patient experience in people with long-term bladder catheterization with T-Control® versus patients with a conventional Foley-type catheter.",[26,27,28],"Catheter-Associated Urinary Tract Infection","Catheter Related Complication","Quality of Life",[30,31,32,33,34],"Catheterisation","T-Control","Foley catheter","Bladder catheter","Urinary catheter","RECRUITING","2026-09-01",{"date":38,"type":39},"2026-09-04","ACTUAL",{"date":41,"type":39},"2023-09-01",{"date":43,"type":20},"2026-12-01",{"name":45,"class":46},"Rethink Medical SL","INDUSTRY",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":21,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":4},"100568239","t-control-safety-for-cytostatics-management-100568239","NCT06678633","T-Control® Safety for Cytostatics Management","Safety and Usability of the T-Control® Catheter in Cytostatics Management: a Pilot Study","Inclusion Criteria:\n\n* Men or women aged ≥18 years.\n* Patients with bladder cancer who require intravesical treatments with chemotherapy or immunotherapy.\n* Patients requiring recurrent intravesical instillations for their treatment.\n* Signed consent agreement.\n\nExclusion Criteria:\n\n* Patients with difficult catheterisation who require a urologist to perform the catheter insertion.\n* Inability to read and understand Portuguese or english.",{"count":55,"type":20},16,[23],"The goal of this pilot clinical trial is to know if this study is feasable in terms of design, recruitment and interventions, as well as gather preliminary data to determine if the T-Control® catheter is safer than the conventional Foley-type catheter during intravesical therapy with oncological patients. It will also learn about the usability of T-Control®. The main questions it aims to answer are:\n\n* Does T-Control® lower the rate of spillages occurred during intravesical treatments?\n* Is T-Control® a better device in terms of usability during intravesical treatments?\n\nResearchers will compare T-Control® catheter to a conventional Foley-type catheter (Folysil® Silicone catheter, Coloplast) to see if T-Control® reduce the rate of accidental spillages.\n\nParticipants will:\n\n* Undergo intravesical therapy with the 2 devices used in the study (in two seuqencial cycles of intravesical treatment): T-Control® catheter (experimental intervention) or Folysil® silicone catheter (control intervention).\n* At the end of the procedure (1-2 hours), the catheter will be removed or changed. During the first visit, patients will be catheterised with the catheter for the randomly assigned intervention, while in the subsequent visit they will be catheterised with the alternate catheter.\n* Healthcare professionals involved in the procedure will take note of spillages and others adverse events occurred during the intravesical instillation.\n* At the end of the study, healthcare proffesionals will evaluate the usability perceived of both devices used for intravesical treatment.",[59],"Non-muscle-invasive Bladder Cancer",[61,62,63,64,32,65],"Intravesical therapy","Inmunotherapy","Chemotherapy","Non-muscle-invasive bladder cancer","Bladder instillation","NOT_YET_RECRUITING","2025-05-23",{"date":69,"type":39},"2025-05-29",{"date":71,"type":20},"2025-11",{"date":73,"type":20},"2027-02",{"name":45,"class":46},""]